Manchester Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Manchester Pharmaceuticals, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VECAMYL and CHENODAL. The owner is based in Mountain View, CA.

P.O. Box 4531

Mountain View, CA 94040

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VECAMYL
VECAMYL
Registered 2011
VERCAL
VERCAL
Abandoned 2011
CHENODAL
CHENODAL
Cancelled 2009
CHENIX
CHENIX
Abandoned 2009
CHENODAL
CHENODAL
Registered 2009
CHENOL
CHENOL
Abandoned 2009

Trademark Classifications

Manchester Pharmaceuticals, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Manchester Pharmaceuticals, Inc. have?

Manchester Pharmaceuticals, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 1 cancelled.

What trademark classes does Manchester Pharmaceuticals, Inc. file in?

Manchester Pharmaceuticals, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Manchester Pharmaceuticals, Inc.'s most well-known trademarks?

Manchester Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as VECAMYL and CHENODAL. These are among 2 currently registered trademarks in the portfolio.

What is Manchester Pharmaceuticals, Inc.'s trademark registration success rate?

Manchester Pharmaceuticals, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.